Compare OTEX & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OTEX | RGC |
|---|---|---|
| Founded | 1991 | 2014 |
| Country | Canada | Hong Kong |
| Employees | N/A | N/A |
| Industry | EDP Services | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.2B | 11.5B |
| IPO Year | 1998 | 2020 |
| Metric | OTEX | RGC |
|---|---|---|
| Price | $22.96 | $23.08 |
| Analyst Decision | Hold | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $37.50 | N/A |
| AVG Volume (30 Days) | ★ 1.9M | 104.8K |
| Earning Date | 05-05-2026 | 01-01-0001 |
| Dividend Yield | ★ 4.71% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.24 | N/A |
| Revenue | ★ $2,815,241,000.00 | N/A |
| Revenue This Year | $2.80 | N/A |
| Revenue Next Year | $1.05 | N/A |
| P/E Ratio | $18.81 | ★ N/A |
| Revenue Growth | ★ 22.88 | N/A |
| 52 Week Low | $22.44 | $9.39 |
| 52 Week High | $39.90 | $950.00 |
| Indicator | OTEX | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 33.75 | 41.77 |
| Support Level | $22.44 | $20.81 |
| Resistance Level | $33.67 | $26.42 |
| Average True Range (ATR) | 0.76 | 2.17 |
| MACD | 0.02 | -0.31 |
| Stochastic Oscillator | 1.37 | 19.38 |
Open Text Corp is engaged in the design, development, marketing, and sale of Information Management software and solutions. Its software allows clients to archive, aggregate, retrieve, and search unstructured information (such as documents, e-mail, and presentations). Its platform and services provide secure and scalable solutions for enterprises, SMBs, governments, and consumers around the world. The company's solutions are marketed and delivered on the OpenText Cloud Platform, which is a comprehensive Information Management platform consisting of six business clouds; Content Cloud, Cybersecurity Cloud, Application Automation Cloud, Business Network Cloud, IT Operations Management Cloud, and Analytics Cloud. Geographically, it derives maximum revenue from the United States.
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.